Starling Oncology, Inc. Deferred Tax Liabilities, Net
Starling Oncology, Inc. (DFPH) had Deferred Tax Liabilities, Net of $0 as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2026-03-12
- 2025-12-31: Deferred Tax Liabilities, Net $0.00.
- 2024-12-31: Deferred Tax Liabilities, Net $32.00K.
- 2023-12-31: Deferred Tax Liabilities, Net $32.00K.
- 2022-12-31: Deferred Tax Liabilities, Net $108.00K.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2024-12-31 | $32.00K 10-K · filed 2026-03-12 |
| 2023-12-31 | $32.00K 10-K · filed 2025-03-26 |
| 2022-12-31 | $108.00K 10-K · filed 2024-03-28 |
| 2021-12-31 | $371.00K 10-K · filed 2023-03-16 |
| 2020-12-31 | $1.61M 10-K · filed 2022-03-11 |